// App-Quantinova.ai

: Risk of Recurrence after Stopping Anticoagulants in Women with Combined Oral Contraceptive-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis

Researchers

Presenter

  • Jameel Abdulrehman

Principal Investigators

  • David Aziz

  • Sameer Parpia

  • Gregoire Le Gal

  • Rouhi Fazelzad

  • Lisbeth Eischer

  • Suzanne Cannegieter

  • Arina J. Ten Cate-Hoek

  • Michael Nagler

  • Sam Schulman

  • Suely M Rezende

  • Valerie Olie

  • Gualtiero Palareti

  • Maura Marcucci

  • James Douketis

  • Daniela Poli

  • Michal Zabczyk

  • Diana Aguiar de Sousa

  • Bruno Miranda

  • Mary Cushman

  • Alberto Tosetto

  • Clive Kearon

  • Leslie Skeith

Medical Centers

  • Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Canada

  • Division of Hematology and Hematological Malignancies, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada

  • Arianna Anticoagulazione Foundation, Bologna, Italy

  • Hospital de Santa Maria, Lisbon School of Medicine, University of Lisbon, Lisbon, Portugal

  • Division of Hematology, Department of Medicine, University Health Network, Toronto, Canada

  • Dept. of Medicine I, Medical University of Vienna, Vienna, Austria

  • Santé publique France, French national public health agency, Saint-Maurice, France

  • Department of Oncology, McMaster University, Hamilton, Canada

  • Department of Health Research Methods, Evidence, and Impact, & Department of Medicine, McMaster University, Hamilton, Canada

  • McMaster University, Hamilton, Canada

  • Physiology Institute - Lisbon School of Medicine, University of Lisbon, Lisbon, Portugal

  • Department of Clinical Chemistry, Inselspital, Bern University Hospital, Bern, Switzerland

  • Institute of Cardiology, Jagiellonian University Medical College and John Paul II Hospital, Krakow, Poland

  • Department of Medicine, St. Joseph's Healthcare Hamilton and McMaster University, Hamilton, Canada

  • Department of Medicine, McGill University, Montreal, Canada

  • Thrombosis Expertise Center, Heart+Vascular Center, Maastricht University Medical Center, Maastricht, Netherlands

  • Library and Information Services, University Health Network - Princess Margaret Cancer Centre, Toronto, Canada

  • Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands

  • Department of Medicine, University of Ottawa, Ottawa, Canada

  • Department of Medicine and Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Canada

  • Hemophilia and Thrombosis Center, Hematology Department, S. Bortolo Hospital, Vicenza, Italy

  • Department of Medicine. Larner College of Medicine, University of Vermont, Burlington, VT

  • Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

Locations

  • Canada

  • Poland

  • Italy

  • Portugal

  • Netherlands

  • Austria

  • Brazil

  • France

  • United States

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

  • Prospective

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved